DR
Derek Rapp
OtherActiveManaging Director at RiverVest Venture Partners
39
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Derek Rapp.
Investment Thesis & Strategy
Derek Rapp, as Managing Director at RiverVest Venture Partners, invests in various stages of biotech, enterprise, health & hospital services, health IT, and pharmaceutical companies. They likely seek innovative companies with strong growth potential within the healthcare and technology sectors.
Investment Activity
Deals per year over the last 1 years
3
2018Portfolio Companies
Selected investments from their portfolio of 39 companies
O
Otonomy
Biotech · Series A, 0
C
Calypso Medical
Healthcare · Seed, 0
V
Velocimed
Healthcare · Seed, 0
L
Lumena Pharmaceuticals
Biotech · Seed, 0
N
Neuros Medical
Healthcare · Series A, 0
X
Xilio Therapeutics
Biotech · Series A, 0
A
Avalyn Pharma
Biotech · Series A, 0
S
Scout Bio
Biotech · Seed, 0
L
Lyric Pharmaceuticals
Biotech · Seed, 0
M
Mirum Pharmaceuticals
Biotech · Series A, 2018
G
Good Therapeutics
Other · , 2018
A
Auxeris Therapeutics
Biotech · Seed, 2018
Frequently Asked Questions
Derek Rapp focuses on Seed, Pre-seed stage investments.